World's Best Scientists 2026 revealed!
John P. Neoptolemos

John P. Neoptolemos

Award Badge
Medicine
Germany
2026

D-Index & Metrics

Medicine

D-Index
140
Citations
90740
World Ranking
1668
National Ranking
83

John P. Neoptolemos publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where John P. Neoptolemos sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 941 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

John P. Neoptolemos D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where John P. Neoptolemos sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 140 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Medicine in Germany Leader Award
  • 2023 - Research.com Medicine in Germany Leader Award
  • 2019 - Member of Academia Europaea
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

John P. Neoptolemos is affiliated with Heidelberg University in Germany and has a research focus primarily in medicine, with significant contributions to biochemistry, genetics, and molecular biology.

Their recent publications cover important topics in oncology and surgery, especially related to pancreatic cancer and pancreatitis. Notable papers include:

  • Neoadjuvant therapy for pancreatic cancer, 2023, Nature Reviews Clinical Oncology
  • Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial, 2022, The Lancet. Gastroenterology & Hepatology
  • A Simple Classification of Pancreatic Duct Size and Texture Predicts Postoperative Pancreatic Fistula, 2021, Annals of Surgery
  • ESPAC-5F: Four-arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer., 2020, Journal of Clinical Oncology
  • Postpancreatectomy Acute Pancreatitis (PPAP), 2021, Annals of Surgery

Their co-authorship network includes frequent collaboration with Thilo Hackert, Markus W. Büchler, Christoph Springfeld, Christopher Halloran, and Jakob R. Izbicki.

Neoptolemos's work is commonly published in specific venues such as:

  • Pancreatology
  • Surgery
  • Annals of Surgery
  • Journal of Clinical Oncology
  • International Journal of Cancer

Their research fields encompass Medicine and Biochemistry, Genetics and Molecular Biology, with subfields focusing on Oncology, Surgery, Cancer Research, Molecular Biology, and Pulmonary and Respiratory Medicine.

The main topics covered in their publications include:

  • Pancreatic and Hepatic Oncology Research
  • Pancreatitis Pathology and Treatment
  • Cancer Genomics and Diagnostics
  • Epigenetics and DNA Methylation
  • Renal Cell Carcinoma Treatment
  • Neuroendocrine Tumor Research Advances
  • Gastrointestinal Disorders and Treatments

John P. Neoptolemos has been recognized with professional distinctions such as becoming a Member of Academia Europaea in 2019 and a Fellow of The Academy of Medical Sciences, United Kingdom.

Best Publications

  • Postoperative pancreatic fistula: an international study group (ISGPF) definition.

    Claudio Bassi;Christos Dervenis;Giovanni Butturini;Abe Fingerhut

  • The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula : 11 Years After

    Claudio Bassi;Giovanni Marchegiani;Christos Dervenis;Micheal Sarr

  • A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer

    John P. Neoptolemos;Deborah D. Stocken;Helmut Friess;Claudio Bassi

  • Delayed gastric emptying (DGE) after pancreatic surgery: A suggested definition by the International Study Group of Pancreatic Surgery (ISGPS)

    Moritz N. Wente;Claudio Bassi;Christos Dervenis;Abe Fingerhut

  • Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition.

    Moritz N. Wente;Johannes A. Veit;Claudio Bassi;Christos Dervenis

  • Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

    John P. Neoptolemos;John P. Neoptolemos;Daniel H. Palmer;Daniel H. Palmer;Paula Ghaneh;Eftychia E. Psarelli

  • Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial

    John P. Neoptolemos;Deborah D. Stocken;Claudio Bassi;Paula Ghaneh

  • IAP Guidelines for the Surgical Management of Acute Pancreatitis

    Waldemar Uhl;Andrew Warshaw;Clement Imrie;Claudio Bassi

  • Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial.

    J. P. Neoptolemos;Janet A. Dunn;D. D. Stocken;J. Almond

  • Controlled trial of urgent endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones.

    J.P. Neoptolemos;N.J. London;D. James;D.L. Carr-Locke

  • European evidence-based guidelines on pancreatic cystic neoplasms

    Marco Del Chiaro;Marc G. Besselink;Lianne Scholten;Marco J. Bruno

  • Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.

    John N Primrose;Richard P Fox;Daniel H Palmer;Hassan Z Malik

  • Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer

    David Cunningham;Ian Chau;Deborah D. Stocken;Juan W. Valle

  • Therapeutic developments in pancreatic cancer: current and future perspectives.

    John P. Neoptolemos;Jörg Kleeff;Jörg Kleeff;Patrick Michl;Eithne Costello

  • Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS).

    Maximilian Bockhorn;Faik G. Uzunoglu;Mustapha Adham;Clem Imrie

  • Inflammatory mediators in acute pancreatitis.

    Madhav Bhatia;Mark Brady;Sheila Shokuhi;Stephen Christmas

  • Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial.

    John P. Neoptolemos;Deborah D. Stocken;Janet A. Dunn;Jennifer Almond

  • Clinical and genetic characteristics of hereditary pancreatitis in Europe

    Nathan Howes;Markus M. Lerch;William Greenhalf;Deborah D. Stocken

  • Optimizing the outcomes of pancreatic cancer surgery

    Oliver Strobel;John Neoptolemos;Dirk Jäger;Markus W Büchler

  • SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis.

    Roland H. Pfützer;M.Michael Barmada;Andrew P.J. Brunskill;Robert Finch

Frequent Co-Authors

Markus W. Büchler
Markus W. Büchler Champalimaud Foundation
Robert Sutton
Robert Sutton University of Liverpool
Claudio Bassi
Claudio Bassi University of Verona
Thilo Hackert
Thilo Hackert Heidelberg University
Markus M. Lerch
Markus M. Lerch Greifswald University Hospital
Oliver Strobel
Oliver Strobel Heidelberg University
David Cunningham
David Cunningham Royal Marsden NHS Foundation Trust
Federico Canzian
Federico Canzian German Cancer Research Center
Juan W. Valle
Juan W. Valle University of Manchester
David L. Carr-Locke
David L. Carr-Locke NewYork–Presbyterian Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative online pathways can be a smart move for individuals passionate about health and medicine in the USA. These routes are often more accessible, flexible, and affordable than traditional on-campus programs.

For nurses seeking advanced roles, online programs offer excellent opportunities. Those interested in doctoral-level study can research the cheapest dnp online program options to find high-quality education at a lower cost. Registered nurses can upgrade their qualifications conveniently through rn to bsn cheapest pathways.

If you do not have a nursing background, many schools offer direct entry msn programs for non-nurses online, allowing a faster transition into this rewarding field. Admission requirements and competitiveness also vary. If ease of entry is a priority, it’s helpful to know whats the easiest nursing program to get into?

Choosing the right online program can open up diverse healthcare career paths while saving you time and money. Explore these options to discover which pathway aligns best with your goals and circumstances.

Best Scientists Citing John P. Neoptolemos

Trending Scientists

Recently Published Articles